Early identification of dengue patients at risk of adverse outcomes is important to prevent
hospital overcrowding in low-to middle-income countries during epidemics. We performed a …

Summary Background Coronavirus disease-2019 (COVID-19) is a global pandemic. Studies
reported dyslipidemia in patients with COVID-19. Herein, we conducted a systematic review …

Abstract Coronavirus disease 2019 (COVID-19) pandemic is affecting millions of patients
worldwide. The consequences of initial exposure to SARS-CoV-2 go beyond pulmonary …

Background Many patients with coronavirus disease 2019 (COVID-19) suffer multiple organ
dysfunctions. However, whether patients develop dyslipidemia is unknown. Objective In this …

The dengue virus nonstructural protein 1 (NS1) is a secreted virulence factor that modulates
complement, activates immune cells and alters endothelial barriers. The molecular basis of …

Low levels of high-density lipoprotein (HDL) and impaired HDL functionality have been
consistently associated with increased susceptibility to infection and its serious …

Background Severe dengue often leads to poor clinical outcomes and high mortality; as a
result, it is of vital importance to find prognostic factors associated with the severe form of …

The kidnapping of the lipid metabolism of the host's cells by severe acute respiratory
syndrome (SARS-CoV-2) allows the virus to transform the cells into optimal machines for its …

The pandemic of coronavirus disease (COVID-19) has become a global threat to public
health. Functional impairments in multiple organs have been reported in COVID-19 …

Dengue, the most important mosquito-borne viral disease transmitted to humans, is caused
by any of the 4 known serotypes of the dengue virus (DENV). Dengue is a systemic disease …